Overview
- According to the parents, the Heidelberg team declined further operations and recommended palliative management, prompting the family to end that treatment relationship.
- The mother reports a recent series of intensive lung procedures described as 50 cuts last week, with results still uncertain.
- Dana Diekmeier says she has spent more than €10,000 on special medications as she searches for any remaining therapies.
- The survival outlook cited by the family stands at about five percent based on what they say doctors have told them.
- The updates come from the mother’s interview with Bunte as relayed by German outlets, and reports differ on tumor details, with accounts citing either an adrenal origin with lung metastases or disease described as in the lung.